Eflucimibe
Product Specifications
CAS Number
202340-45-2
Target
Acyltransferase
Related Pathways
Metabolism
Purity
>99.99%
Bioactivity
Eflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia.
Smiles
[C@H](C(NC1=C(C)C(C)=C(O)C(C)=C1)=O)(SCCCCCCCCCCCC)C2=CC=CC=C2
Molecular Formula
C29H43NO2S
Molecular Weight
469.72
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15330400 1 Vial
Lentiviral human ZNF816-ZNF321P shRNA (UAS) - Lentiviral human ZNF816-ZNF321P shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details MBS1144072-01 0.02 mg (E-Coli)
Recombinant Brucella suis Urease accessory protein UreD (ureD)
Sign In for Pricing
View Details MBS1144072-02 0.02 mg (Yeast)
Recombinant Brucella suis Urease accessory protein UreD (ureD)
Sign In for Pricing
View Details MBS1144072-03 0.1 mg (E-Coli)
Recombinant Brucella suis Urease accessory protein UreD (ureD)
Sign In for Pricing
View Details